Market Summary
USD33.98-0.59
Market Closed-1.71%
PRGO Stock Price
PRGO RSI Chart
PRGO Valuation
PRGO Price/Sales (Trailing)
PRGO Profitability
PRGO Fundamentals
PRGO Revenue
PRGO Earnings
Price Action
52 Week Range
30.7843.90
(Low)(High)
Last 7 days
-3.2%
Last 30 days
-0.2%
Last 90 days
12.5%
Trailing 12 Months
-5.4%
PRGO Financial Health
PRGO Investor Care
Peers (Alternatives to Perrigo Company)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
JNJ | 404.8B | 94.9B | -5.16% | -10.64% | 22.56 | 4.26 | 1.25% | -14.07% |
LLY | 296.8B | 28.5B | -5.67% | 20.74% | 47.53 | 10.4 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | -1.75% | 40.02% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 226.4B | 100.3B | -8.43% | -20.95% | 7.22 | 2.26 | 23.43% | 42.74% |
BMY | 142.7B | 46.2B | -7.78% | -1.12% | 22.55 | 3.09 | -0.49% | -9.54% |
| MID-CAP | ||||||||
PRGO | 4.8B | 4.5B | -0.20% | -5.41% | -34.17 | 1.08 | 7.56% | -104.06% |
RETA | 3.3B | 2.2M | 105.10% | 171.03% | -10.52 | 1.5K | -80.71% | -4.88% |
| SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -9.96% | 17.66% | 31.57 | 2.87 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -17.77% | -52.80% | -2.74 | 2.63 | 18.18% | -18.59% |
CGC | 991.7M | 478.9M | -11.35% | -65.42% | -0.32 | 2.07 | -31.50% | -634.70% |
INVA | 792.9M | 285.2M | -7.22% | -37.95% | 3.6 | 2.78 | -27.21% | -40.28% |
CRON | 768.8M | 114.5M | -15.28% | -37.42% | -4.56 | 6.72 | 27.90% | 57.40% |
ACRS | 541.5M | 29.8M | -40.95% | -47.43% | -6.23 | 18.2 | 340.05% | 4.35% |
OCUL | 400.7M | 51.5M | -2.49% | -0.39% | -5.64 | 7.78 | 18.32% | -984.05% |
ENDP | 94.1M | 2.3B | -43.99% | -88.43% | -0.03 | 0.04 | -22.53% | -376.66% |
Financials for Perrigo Company
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.1% | 4,452 | 4,401 | 4,344 | 4,203 | 4,139 |
| Gross Profit | 1.4% | 1,455 | 1,435 | 1,409 | 1,386 | 1,416 |
| Operating Expenses | 2.7% | 1,377 | 1,341 | 909 | 1,005 | 1,006 |
| S&GA Expenses | 4.0% | 585 | 562 | 548 | 537 | 536 |
| R&D Expenses | 1.8% | 123 | 121 | 119 | 120 | 122 |
| Interest Expenses | -7.1% | -156 | -145 | -135 | -128 | -125 |
| Net Income | -31.0% | -140 | -107 | -116 | -109 | -68.90 |
| Net Income Margin | -29.6% | -0.03* | -0.02* | -0.03* | -0.03* | - |
| Free Cahsflow | 320.4% | 211 | -95.70 | 168 | 108 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 3.2% | 11,017 | 10,678 | 10,920 | 10,390 | 10,426 |
| Current Assets | 5.3% | 2,720 | 2,583 | 2,652 | 3,936 | 3,860 |
| Cash Equivalents | 28.2% | 601 | 469 | 485 | 1,966 | 1,865 |
| Inventory | 6.0% | 1,150 | 1,085 | 1,080 | 1,022 | 1,020 |
| Net PPE | 10.3% | 926 | 840 | 840 | 846 | 864 |
| Goodwill | -2.4% | 3,429 | 3,515 | 2,971 | 2,999 | - |
| Liabilities | 1.7% | 6,175 | 6,075 | 6,070 | 5,285 | 5,274 |
| Current Liabilities | 9.7% | 1,114 | 1,015 | 1,015 | 981 | 1,588 |
| LT Debt, Current | 8.1% | 36.00 | 34.00 | 31.00 | 5.00 | 604 |
| LT Debt, Non Current | -0.2% | 4,070 | 4,078 | 4,086 | 3,511 | 2,917 |
| Shareholder's Equity | 5.2% | 4,842 | 4,603 | 4,850 | 5,105 | 5,152 |
| Retained Earnings | -1.2% | -2,067 | -2,043 | -1,994 | -1,929 | -1,927 |
| Shares Outstanding | 0% | 135 | 135 | 134 | - | - |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | 1820.6% | 307 | 16.00 | 301 | 235 | 156 |
| Share Based Compensation | -3.0% | 55.00 | 57.00 | 58.00 | 61.00 | 60.00 |
| Cashflow From Investing | 0.8% | -1,958 | -1,974 | -500 | 1,453 | 1,276 |
| Cashflow From Financing | 3.8% | 422 | 406 | 413 | -187 | -178 |
| Dividend Payments | 2.6% | 142 | 139 | 134 | 131 | 130 |
| Buy Backs | NaN% | 0.00 | 0.00 | - | - | - |
Risks for PRGO
What is the probability of a big loss on PRGO?
87.3%
Probability that Perrigo Company stock will be more than 20% underwater in next one year
37.7%
Probability that Perrigo Company stock will be more than 30% underwater in next one year.
18.9%
Probability that Perrigo Company stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does PRGO drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Perrigo Company was unfortunately bought at previous high price.
Drawdowns
Returns for PRGO
Cumulative Returns on PRGO
-10.2%
10-Year Cumulative Returns
-16.0%
7-Year Cumulative Returns
-14.5%
5-Year Cumulative Returns
-6.8%
3-Year Cumulative Returns
What are the long-term rolling returns for PRGO?
FIve years rolling returns for Perrigo Company.
Annualized Returns
Which funds bought or sold PRGO recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.04 | -901,717 | 35,822,300 | 0.04% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 108 | 46,000 | 91,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 6.81 | 20,553 | 987,553 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | added | 3.9 | -808 | 58,192 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 9.12 | 31,000 | 735,000 | 0.01% |
2023-02-21 | Insight Advisors, LLC/ PA | new | - | 301,350 | 301,350 | 0.10% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -1.2 | -472,000 | 7,159,000 | 0.01% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | new | - | 3,579 | 3,579 | -% |
2023-02-17 | Coppell Advisory Solutions Corp. | new | - | 205 | 205 | -% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -19.37 | -2,125,390 | 7,150,610 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Perrigo Company News
Schedule 13G FIlings of Perrigo Company
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 15, 2023 | barrow hanley mewhinney & strauss llc | 7.30% | 9,825,539 | SC 13G | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 10.84% | 14,590,276 | SC 13G/A | |
| Jan 24, 2023 | blackrock inc. | 9.8% | 13,221,594 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 8.0% | 10,721,574 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 8.6% | 11,557,239 | SC 13G/A | |
| Jan 10, 2022 | barrow hanley mewhinney & strauss llc | 10.10% | 13,505,133 | SC 13G | |
| Nov 10, 2021 | price t rowe associates inc /md/ | 8.4% | 11,328,393 | SC 13G/A | |
| Sep 10, 2021 | price t rowe associates inc /md/ | 18.0% | 24,135,892 | SC 13G/A |
PRGO Fair Value
Perrigo Company fair value in different scenarios
The table shows the Fair Value estimates for Perrigo Company for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | - - | - - | - - | - - | - - |
| Current Inflation | 17.39 -48.82% | 19.63 -42.23% | 23.67 -30.34% | 26.94 -20.72% | 29.79 -12.33% |
| Very High Inflation | - - | - - | - - | - - | - - |
Historical Perrigo Company Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Perrigo Company
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 14, 2023 | 4 | Insider Trading | |
| Mar 14, 2023 | 4 | Insider Trading | |
| Mar 10, 2023 | PRE 14A | PRE 14A | |
| Mar 09, 2023 | 4 | Insider Trading | |
| Mar 09, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for PRGO
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-13 | Farrington Thomas | sold | -132,435 | 35.572 | -3,723 | evp and cio |
2023-03-10 | Dillard James E III | sold | -321,309 | 35.701 | -9,000 | evp & president csca |
2023-03-08 | Janish Ronald Craig | sold | -166,133 | 36.9185 | -4,500 | evp, gbl ops & sc & cto |
2023-03-07 | Quinn Grainne | acquired | 84,847 | 37.71 | 2,250 | evp, chief medical officer |
2023-03-07 | Willis Robert | sold (taxes) | -42,423 | 37.71 | -1,125 | evp & chro |
2023-03-07 | Quinn Grainne | sold (taxes) | -44,120 | 37.71 | -1,170 | evp, chief medical officer |
2023-03-07 | Janish Ronald Craig | acquired | 110,943 | 37.71 | 2,942 | evp, gbl ops & sc & cto |
2023-03-07 | Ives Alison | acquired | 65,841 | 37.71 | 1,746 | evp & chief scientific officer |
2023-03-07 | Farrington Thomas | sold (taxes) | -43,705 | 37.71 | -1,159 | evp and cio |
2023-03-07 | KESSLER MURRAY S | sold (taxes) | -446,864 | 37.71 | -11,850 | ceo |
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PRGO Income Statement
2022-12-31Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Income Statement [Abstract] | |||
| Net sales | $ 4,451.6 | $ 4,138.7 | $ 4,088.2 |
| Cost of sales | 2,996.2 | 2,722.5 | 2,593.3 |
| Gross profit | 1,455.4 | 1,416.2 | 1,494.9 |
| Operating expenses | |||
| Distribution | 113.0 | 93.0 | 85.1 |
| Research and development | 123.1 | 122.0 | 121.7 |
| Selling | 584.8 | 536.4 | 545.5 |
| Administration | 512.3 | 482.0 | 478.5 |
| Impairment charges | 0.0 | 173.1 | 0.0 |
| Restructuring | 42.5 | 16.9 | 3.2 |
| Other operating expense (income), net | 0.8 | (417.6) | (4.3) |
| Total operating expenses | 1,376.5 | 1,005.8 | 1,229.7 |
| Operating income | 78.9 | 410.4 | 265.2 |
| Change in financial assets | 0.0 | 0.0 | 95.3 |
| Interest expense, net | 156.0 | 125.0 | 127.7 |
| Other (income) expense, net | 53.1 | 26.7 | 16.3 |
| Loss on extinguishment of debt | 8.9 | 0.0 | 20.0 |
| Income (loss) from continuing operations before income taxes | (139.1) | 258.7 | 5.9 |
| Income tax expense (benefit) | (8.2) | 389.6 | (38.3) |
| Income (loss) from continuing operations | (130.9) | (130.9) | 44.2 |
| Income (loss) from discontinued operations, net of tax | (9.7) | 62.0 | (206.8) |
| Net income (loss) | $ (140.6) | $ (68.9) | $ (162.6) |
| Basic | |||
| Continuing operations (in dollars per share) | $ (0.97) | $ (0.98) | $ 0.32 |
| Discontinued operations (in dollars per share) | (0.07) | 0.46 | (1.52) |
| Basic (in dollars per share) | (1.04) | (0.52) | (1.20) |
| Diluted | |||
| Continuing operations (in dollars per share) | (0.97) | (0.98) | 0.32 |
| Discontinued operations (in dollars per share) | (0.07) | 0.46 | (1.51) |
| Diluted (in dollars per share) | $ (1.04) | $ (0.52) | $ (1.19) |
| Weighted-average shares outstanding | |||
| Basic (in shares) | 134.5 | 133.6 | 136.1 |
| Diluted (in shares) | 134.5 | 133.6 | 137.2 |
PRGO Balance Sheet
2022-12-31Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $ 600.7 | $ 1,864.9 |
| Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively | 697.1 | 652.9 |
| Inventories | 1,150.3 | 1,020.2 |
| Prepaid expenses and other current assets | 271.8 | 305.8 |
| Current assets held for sale | 0.0 | 16.1 |
| Total current assets | 2,719.9 | 3,859.9 |
| Property, plant and equipment, net | 926.3 | 864.1 |
| Operating lease assets | 217.1 | 166.9 |
| Goodwill and indefinite-lived intangible assets | 3,549.0 | 3,004.7 |
| Definite-lived intangible assets, net | 3,230.2 | 2,146.1 |
| Deferred income taxes | 7.1 | 6.5 |
| Other non-current assets | 367.7 | 377.5 |
| Total non-current assets | 8,297.4 | 6,565.8 |
| Total assets | 11,017.3 | 10,425.7 |
| Liabilities and Shareholders’ Equity | ||
| Accounts payable | 537.3 | 411.2 |
| Payroll and related taxes | 136.4 | 118.5 |
| Accrued customer programs | 139.1 | 125.6 |
| Other accrued liabilities | 250.2 | 279.4 |
| Accrued income taxes | 14.4 | 16.5 |
| Current indebtedness | 36.2 | 603.8 |
| Current liabilities held for sale | 0.0 | 32.9 |
| Total current liabilities | 1,113.6 | 1,587.9 |
| Long-term debt, less current portion | 4,070.4 | 2,916.7 |
| Deferred income taxes | 368.2 | 239.3 |
| Other non-current liabilities | 623.0 | 530.1 |
| Total non-current liabilities | 5,061.6 | 3,686.1 |
| Total liabilities | 6,175.2 | 5,274.0 |
| Contingencies - Refer to Note 19 | ||
| Controlling interests: | ||
| Preferred shares, $0.0001 par value per share, 10 shares authorized | 0.0 | 0.0 |
| Ordinary shares, €0.001 par value per share, 10,000 shares authorized | 6,936.7 | 7,043.2 |
| Accumulated other comprehensive income | (27.0) | 35.5 |
| Retained earnings (accumulated deficit) | (2,067.6) | (1,927.0) |
| Total shareholders’ equity | 4,842.1 | 5,151.7 |
| Total liabilities and shareholders' equity | $ 11,017.3 | $ 10,425.7 |
| Supplemental Disclosures of Balance Sheet Information | ||
| Preferred shares, issued and outstanding | 0.0 | 0.0 |
| Ordinary shares, issued and outstanding | 134.7 | 133.8 |